St. Paul, MN – A groundbreaking investigation by The 74 Million, revealing the unchecked proliferation of private equity firms within the autism therapy sector, has ignited a legislative push in Minnesota. Two prominent Democratic-Farmer-Labor (DFL) state senators, Zaynab Mohamed of Minneapolis and Scott Dibble, also representing Minneapolis, have announced their intent to introduce sweeping legislation aimed at regulating the opaque influence of Wall Street investment on providers of Applied Behavior Analysis (ABA) therapy. This move signals a growing concern over the ethical implications and quality of care when profit motives potentially overshadow the well-being of vulnerable children.
Senator Mohamed minced no words in expressing her dismay, stating, “This report is outrageous. The idea that Wall Street investors are exploiting these programs for profit is infuriating.” Her sentiments echo a rising tide of national apprehension regarding the commercialization of essential healthcare services, particularly those catering to individuals with disabilities. The proposed legislation seeks to inject transparency and accountability into an industry that has seen explosive growth and significant private investment, often with limited oversight.
The Genesis of Reform: The 74 Million Investigation Unveils Systemic Concerns
The catalyst for this legislative action is a comprehensive investigation by The 74 Million, a national education news organization, which brought to light a disturbing trend over the past decade. Private equity investors, operating with notably limited regulatory scrutiny, have systematically acquired hundreds of independent, often family-run, autism therapy centers across the nation, including in Minnesota. These acquisitions have consolidated what were once localized services into sprawling, lucrative networks, fundamentally altering the landscape of autism care.
The financial ramifications of this consolidation are staggering. The investigation revealed that nationwide Medicaid reimbursements for Applied Behavior Analysis (ABA) — a behavioral conditioning therapy often prescribed for autistic children — surged dramatically from $400 million in 2019 to nearly $2 billion in 2024. This nearly five-fold increase in just five years underscores the rapid expansion and financial allure of the sector. The 74 Million’s analysis of U.S. Centers for Medicare and Medicaid records further illuminated this trend, finding that private equity firms now own almost half of the 50 companies with the highest claims. These firms alone accounted for a colossal $3.1 billion of the almost $7 billion billed for ABA services during the investigation’s six-year review period, illustrating their dominant financial footprint.
Beyond the sheer volume of claims, the investigation also cast a critical eye on the efficacy and potential drawbacks of ABA itself. Building on prior reporting, The 74 Million highlighted the "weak evidence base" supporting certain applications of ABA, particularly when administered intensively to children as young as two years old for up to 40 hours a week. The therapy, designed to "extinguish" autistic traits through a system of rewards and punishments, has faced increasing scrutiny from autistic self-advocates and researchers. Recent studies cited in the report point to concerning outcomes, including heightened rates of Post-Traumatic Stress Disorder (PTSD) and psychiatric hospitalizations among individuals who underwent the intervention. This raises profound questions about the long-term well-being of patients subjected to practices driven by a profit-maximization model.
The Private Equity Playbook in Healthcare: A Familiar Pattern
The entry of private equity into the autism therapy sector mirrors a broader trend observed across various healthcare industries. Private equity firms typically employ a strategy of acquiring privately held companies, often through leveraged buyouts, with the aim of consolidating fragmented markets, optimizing operations for efficiency and profit, and then selling them off, usually within three to seven years, for a substantial return on investment. This business model, while common in other sectors, presents unique ethical challenges when applied to healthcare, where patient well-being, not just financial return, is paramount.
As private equity money poured into ABA, large for-profit providers frequently shifted their operations from states with lower Medicaid reimbursement rates to those offering more attractive benefits. This strategic relocation underscores the profit-driven nature of these entities, prioritizing financial gain over equitable access to care across different regions. Minnesota, alongside a handful of other states that have proactively sought to make services accessible to a broad spectrum of families with disabled children, has inadvertently become an attractive and lucrative market for these large industry players. The state’s commitment to its most vulnerable populations, ironically, has made it a target for investment strategies that may not align with its public health objectives.
Senator Dibble, a veteran legislator with a history of advocating for healthcare transparency, drew direct parallels between the current situation in autism therapy and previous private equity incursions into other care sectors. "The impact of this cycle on applied behavior analysis mirrors what has happened in other healthcare industries," Dibble stated. He previously authored a bill last year mandating disclosure of ownership for nursing homes and assisted living facilities acquired by for-profit companies, a bill that ultimately did not pass into law. His experience highlights a persistent challenge in holding corporate entities accountable when their ownership structures are deliberately opaque. A recent investigation by state healthcare monitors in Minnesota, for instance, found that 79% of complaints regarding abuse and neglect in long-term care facilities involved for-profit companies, reinforcing the link between profit motives and potential compromises in patient care.
Minnesota’s Vulnerability and Broader Medicaid Scrutiny
Minnesota’s appeal to private equity firms is multifaceted. The state has historically demonstrated a robust commitment to providing comprehensive services for individuals with disabilities, resulting in favorable Medicaid reimbursement rates that entice providers. However, this attractiveness has also made it vulnerable to unchecked profiteering.
The current legislative push comes at a critical juncture for Minnesota’s healthcare funding. The "One Big Beautiful Bill Act," a significant piece of federal legislation, is projected to slash Medicaid spending, placing increased pressure on states to manage their budgets while sustaining essential children’s benefits. In this context, any waste, fraud, or undue profiteering within the system becomes even more detrimental, threatening the stability of services for those who need them most.
Moreover, Minnesota has faced intense scrutiny regarding Medicaid reimbursement for autism therapy in recent years. The state, in particular, drew the ire of the previous Trump administration, which cited alleged Medicaid abuse as a justification for violent Immigration and Customs Enforcement (ICE) incursions into the Twin Cities in the winter of 2024. While these federal actions were primarily framed around rooting out fraud perpetrated by immigrants, the broader narrative underscores a national concern about the integrity of Medicaid spending. In February, the Department of Government Efficiency released a massive 275 million-record Medicaid dataset, ostensibly to combat waste, fraud, and abuse. However, The 74 Million’s analysis of this very data revealed a different systemic problem: not just isolated fraud, but widespread, unchecked profiteering and lax state and federal oversight of ABA providers, coupled with the rapid acquisition of these providers by private equity. This shift in focus from individual perpetrators to systemic vulnerabilities highlights the urgent need for structural reforms.
Legislative Proposals: A Call for Transparency and Accountability
Senators Mohamed and Dibble are proposing a multi-pronged legislative approach designed to address the systemic issues uncovered by The 74 Million’s investigation. Their primary objectives are to ensure transparent reporting of ownership for autism services centers and to empower the state to effectively regulate entities whose profit-driven business models demonstrably compromise the quality of children’s care.
Central to their proposals is a demand for greater transparency in ownership. Senator Dibble passionately articulated the need for this, stating, "It’s not enough to have a P.O. box in New Jersey. I think we’re entitled to know — this particular entity, what else do they own, and how well have they provided services?" He drew a compelling analogy to the rigorous vetting required for a liquor license, suggesting that a similar standard of public trust should apply to entities entrusted with the care of vulnerable children. "Before someone can come in and purchase a liquor license, they need to prove that they’re an outstanding citizen who hasn’t participated in any shady practices and they can be entrusted with the public trust that a publicly issued license entails." This suggests a desire for comprehensive disclosure, including the full corporate structure, financial interests, and track record of all related entities.
Beyond mere disclosure, the senators also seek to establish the power to weed out problematic providers. This could involve enhanced licensing requirements, stricter criteria for Medicaid participation, and mechanisms to review and potentially revoke licenses from providers whose profit motives are found to consistently undermine patient care. The goal is to move beyond a reactive system that only addresses fraud after the fact, towards a proactive regulatory framework that prevents exploitation before it occurs.
Furthermore, Senator Dibble advocates for requiring providers to spend a certain amount of the reimbursements they receive on direct patient care. This proposed "patient care ratio" would establish a floor for how much of public funds must directly benefit the autistic children receiving therapy, rather than being diverted to administrative overhead, executive salaries, or investor profits. "This kind of aggressive super-sized profit motive is totally inappropriate in these settings because it incentivizes behaviors that don’t support the public’s interest and good use of public dollars," Dibble asserted. Such a requirement would act as a crucial safeguard against excessive profiteering, ensuring that Medicaid dollars are primarily utilized for their intended purpose: delivering high-quality, accessible care.
The Broader Implications: Patient Welfare, Fiscal Responsibility, and Ethical Quandaries
The outcome of this legislative effort in Minnesota carries significant implications, extending far beyond the state’s borders.
For Patient Welfare: The most profound impact would be on autistic children and their families. Unchecked profiteering can lead to critical compromises in care quality, including high staff turnover, inadequate training for therapists, pressure to maximize billable hours regardless of clinical need, and a focus on short-term gains rather than holistic, individualized patient development. When private equity firms exit, often leaving behind substantial debt, autism therapy centers can face bankruptcy or closure, leaving families scrambling to find new providers and disrupting crucial, often long-term, therapeutic interventions. The potential for harm, both through ineffective or harmful therapy and through disruption of care, is immense for a population that thrives on consistency and individualized support.
For Fiscal Responsibility: From a fiscal perspective, the current system allows for substantial public funds, through Medicaid, to be siphoned into private profits rather than direct patient care. As state budgets tighten under federal mandates like the One Big Beautiful Bill Act, ensuring that every public dollar is spent efficiently and effectively becomes paramount. Regulation that mandates spending on patient care and ensures accountability could lead to more sustainable and equitable allocation of resources, ultimately benefiting more families within existing budgetary constraints.
Ethical Quandaries: At its heart, this debate touches upon fundamental ethical questions about the role of profit in healthcare, particularly for vulnerable populations. The conflict between a fiduciary duty to maximize shareholder returns and an ethical obligation to prioritize patient well-being is stark. While private investment can sometimes help expand access to care, the current model appears to prioritize extraction of value over the provision of quality services. The legislative proposals in Minnesota seek to rebalance this equation, asserting that the public trust inherent in healthcare provision necessitates a different standard of accountability than a typical commercial enterprise.
The move by Senators Mohamed and Dibble in Minnesota represents a significant step towards addressing a systemic issue that impacts vulnerable populations nationwide. Their proposed legislation, if successful, could serve as a model for other states grappling with the growing influence of private equity in critical healthcare sectors. The battle for transparency and accountability in autism therapy is not merely a bureaucratic skirmish; it is a fight for the integrity of care and the protection of those who depend on it most. The coming legislative session will undoubtedly be a pivotal moment for the future of autism care in Minnesota and potentially across the country.
